COEUR D’ALENE, Idaho — In his role as Allergan’s senior vice president of specialty therapeutics, Jag Dosanjh conducts “crucial conversations” every day.
These conversations are often uncomfortable. “Stakes are high, opinions vary, and emotions run high,” Dosanjh said in a presentation at the Women in Ophthalmology Summer Symposium.
Knowing that a level of conflict is likely between the parties engaging in these conversations, navigating those discussions takes “effort, thought and preparation,” he said.
“It’s not going to become
Uncategorized